StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Alimta (pemetrexed) by Quarter

Alimta (pemetrexed) — Worldwide revenue ($M) [legacy separate disclosure] ($M)

QuarterlyAnnual

Eli Lilly Alimta (pemetrexed): $44.9M in Q4 2023, down 81.0% from a year earlier. That is the lowest of the 28 quarters on record here. No newer figure appears in the documents we track.

Latest, Q4 2023
44.9
Period ended Dec 31, 2023
Change on a year earlier
-81.0%
237 in Q4 2022
History
28 quarters
Since Q1 2017
Sources
24
Documents cited below

Where the Q4 2023 figure comes from

“|| Alimta | 44.9 | 236.6 | (81)% | 217.5 | 927.7 | (77)%”

Source: Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗

Reported in Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAlimta (pemetrexed) — Worldwide revenue ($M) [legacy separate disclosure] ($M)Year on yearSource
Q4 2023Dec 31, 202344.9-81.0%Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 202353.5-55.2%Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 202360.9-73.3%Form 10-Q (filed 2023-08-08) ↗
Q1 2023Mar 31, 202358.2-83.1%Form 10-Q (filed 2023-04-27) ↗
Q4 2022Dec 31, 2022237-45.6%Earnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 2022119-73.9%Form 10-Q (filed 2023-11-02) ↗
Q2 2022Jun 30, 2022228-62.7%Form 10-Q (filed 2023-08-08) ↗
Q1 2022Mar 31, 2022344-38.5%Form 10-Q (filed 2023-04-27) ↗
Q4 2021Dec 31, 2021435-33.4%Earnings Release (Form 8-K FY2021Q4 EX-99.1) (filed 2022-02-03) ↗
Q3 2021Sep 30, 2021457-20.9%Form 10-Q (filed 2022-11-01) ↗
Q2 2021Jun 30, 2021611+13.3%Form 10-Q (filed 2022-08-04) ↗
Q1 2021Mar 31, 2021559-0.2%Form 10-Q (filed 2022-04-29) ↗
Q4 2020Dec 31, 2020653+23.0%Earnings Release (Form 8-K FY2020Q4 EX-99.1) (filed 2021-01-29) ↗
Q3 2020Sep 30, 2020578+13.7%Form 10-Q (filed 2021-10-27) ↗
Q2 2020Jun 30, 2020539-6.7%Form 10-Q (filed 2021-08-03) ↗
Q1 2020Mar 31, 2020560+12.2%Form 10-Q (filed 2021-04-30) ↗

Breakdown

What makes up alimta (pemetrexed)

Cite this data

StockData. (2026). Eli Lilly Alimta (pemetrexed) ($M), quarterly Q1 2017–Q4 2023 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-alimta-ww

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.